Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richard, A.
Right arrow Articles by Harrison, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richard, A.
Right arrow Articles by Harrison, T.
American Journal of Health-System Pharmacy, Vol 59, Issue 4, 372-377
Copyright © 2002 by American Society of Health-System Pharmacists


Articles

Efficacy of HMG-CoA reductase inhibitors in treating osteoporosis

AA Richard and TM Harrison


The Therapy Consultation section provides brief advice, in question-and-answer format, on how to handle specific drug-therapy problems. Readers are invited to submit questions, which will be referred to a consultant for an answer. The problems should not be highly specialized or unusual, nor should they be mundane. Questions are answered briefly, largely on the basis of judgment and personal experience of the consultant, although selected references may be cited to substantiate the consultant's advice.
 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society of Health-System Pharmacists.